The ROE as of April 2025 (TTM) for Ascentage Pharma Group International (ASPHF) is -78.68%

According to Ascentage Pharma Group International’s latest financial reports and current stock price. The company's current ROE is -78.68%. This represents a change of -72.10% compared to the average of -282.06% of the last 4 quarters.

Ascentage Pharma Group International (ASPHF) Historical ROE (quarterly & annually)

How has ASPHF ROE performed in the past?

The mean historical ROE of Ascentage Pharma Group International over the last ten years is -149.88%. The current -78.68% ROE has changed -47.50% with respect to the historical average. Over the past ten years (40 quarters), ASPHF's ROE was at its highest in in the June 2019 quarter at 39.01%. The ROE was at its lowest in in the December 2023 quarter at -866.12%.

Ascentage Pharma Group International (ASPHF) ROE by Quarter and Year

Discovering the peaks and valleys of Ascentage Pharma Group International ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascentage Pharma Group International (ASPHF) Average ROE

How has ASPHF ROE performed in the past?

The current ROE of Ascentage Pharma Group International (ASPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ascentage Pharma Group International (ASPHF) ROE vs. Peers

How is ASPHF’s ROE compared to its peers?

Ascentage Pharma Group International’s ROE is greater than Cellectis S.A. (-29.43%), greater than Biotron Limited (-1317.28%), greater than Dermata Therapeutics, Inc. (-366.01%), greater than Kane Biotech Inc. (-94.49%), less than Covalon Technologies Ltd. (18.98%), less than Bioasis Technologies Inc. (0%), greater than Antibe Therapeutics Inc. (-49.77%), less than Arch Therapeutics, Inc. (89.10%), less than Awakn Life Sciences Corp. (231.42%), greater than Protagenic Therapeutics, Inc. (-474.57%), less than Sino Biopharmaceutical Limited (10.80%), less than ZIVO Bioscience, Inc. (747.50%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Eledon Pharmaceuticals, Inc. (-54.23%), greater than Applied Molecular Transport Inc. (-131.59%), less than Catalyst Biosciences, Inc. (46.88%), greater than Aileron Therapeutics, Inc. (-102.26%), less than Bio-Path Holdings, Inc. (2.09%), greater than Benitec Biopharma Inc. (-43.07%),

Build a custom stock screener for Ascentage Pharma Group International (ASPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascentage Pharma Group International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascentage Pharma Group International (ASPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascentage Pharma Group International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.